<DOC>
	<DOCNO>NCT00167245</DOCNO>
	<brief_summary>The primary purpose study test effectiveness topiramate treatment combine alcohol cocaine dependence . Topiramate approve treatment seizure . It proven effective treatment alcohol cocaine dependence .</brief_summary>
	<brief_title>Topiramate Alcohol Cocaine Dependence</brief_title>
	<detailed_description>The purpose study evaluate efficacy 300 mg/day topiramate treatment 200 treatment-seeking alcohol dependent outpatient comorbid cocaine dependence double-blind , placebo-controlled 14-week trial , 6-month follow-up ( 3 month complete medication ) .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Male female , 18 year old . Meets DSM ( Diagnostic Statistical Manual ) IV criterion current diagnosis cocaine alcohol dependence , determine SCID ( Structured Clinical Interview DSM ) IV . In past 30 day , use less $ 200worth cocaine meet follow drinking criterion measure Timeline Followback ( TLFB ) ( Sobell Sobell , 1995 ) a. drank within 30 day intake day , b. report minimum 48 standard alcoholic drink ( avg . 12 drinks/wk ) consecutive 30day period 90day period prior start intake ( i.e. , minimum 40 % day drinking ) , c. 2 day heavy drinking ( defined 5 drink per day male 4 drink per day female ) pretreatment period . Two consecutive day abstinence cocaine alcohol , determine selfreports confirm negative urine toxicology screen , negative breathalyzer test , collateral report , Clinical Institute Withdrawal Scale Alcohol ( CIWAAR ) ( Sullivan et al. , 1989 ) score eight , . Subjects encourage achieve 3 consecutive day abstinence , however , subject achieve 2 consecutive day abstinence include approval principal investigator . We anticipate subject comprise less 5 % total enrolled subject . Subjects give 2 additional week beyond screen week attain appropriate period cocaine alcohol abstinence prior randomization . Lives commutable distance Treatment Research Center ( TRC ) agree attend research visit include followup visit . Speaks , understand , print English . Abstinent cocaine alcohol 30 consecutive day prior sign consent form . Meets DSMIV criterion dependence substance cocaine alcohol ( except nicotine cannabis ) , determine SCID . Needs treatment psychoactive medication include antiseizure medication ( exception Benadryl use sparingly , necessary , sleep ) . Current use phenytoin drug similar class . Meets DSMIV criterion schizophrenia psychotic disorder , organic mental disorder . Subject meet current DSMIV diagnosis clinically significant psychiatric disorder interfere study participation . Has evidence history significant hematological , pulmonary , endocrine , cardiovascular , renal gastrointestinal disease . Severe physical medical illness AIDS , active hepatitis , significant hepatocellular injury evidence elevated bilirubin level ( &gt; 1.3 ) , elevate level ( 3.5x normal ) aspartate aminotransferase ( AST ) , serum glutamicpyruvic transaminase ( SGPT ) require 3 day abstinence , severe renal disease , severe respiratory disease severe diarrhea result metabolic acidosis , serum bicarbonate ( &lt; 20 milliequivalent ( mEq ) /L ) History epilepsy seizure disorder . Use investigational medication 30 day prior randomization . History nephrolithiasis ( kidney stone ) . History hypersensitivity topiramate . Is female test positive pregnancy test , contemplate pregnancy next 6 month , nursing , use effective contraceptive method ( relevant ) . Acceptable method contraception include barrier method ( diaphragm condom spermicide , intrauterine progesterone contraceptive system , levonorgestrel implant , medroxyprogesterone acetate contraceptive injection ) . Current use carbonic anhydrase inhibitor . A history glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Topiramate</keyword>
	<keyword>alcoholism</keyword>
	<keyword>cocaine dependence</keyword>
</DOC>